Paper Search Console

Home Search Page About Contact

Journal Title

Title of Journal: Adv Ther

Search In Journal Title:

Abbravation: Advances in Therapy

Search In Journal Abbravation:

Publisher

Springer Healthcare

Search In Publisher:

DOI

10.1007/s00216-011-5357-9

Search In DOI:

ISSN

1865-8652

Search In ISSN:
Search In Title Of Papers:

When People with OpioidInduced Constipation Speak

Authors: Robert S Epstein J Russell Teagarden Ali Cimen Mark Sostek Tehseen Salimi
Publish Date: 2017/02/08
Volume: 34, Issue: 3, Pages: 725-731
PDF Link

Abstract

Opioidinduced constipation OIC is a common consequence of opioid use for chronic pain OIC creates problems for patients independent of their pain syndromes in addition to threatening pain treatment effectiveness Healthcare practitioners need to be alert to how patients talk about OIC so that it is not missed Using a survey mechanism we sought patient expressions of the personal impact OIC imposes on how they are able to live their lives and on meanings that symptom relief would produceWe used an online survey asking adults with OIC about quality of life implications of OIC and focused on openended text responses to questions about personal impacts of straining and meanings attached to OIC symptom relief Participants were from the US Canada UK Germany Sweden and NorwayA survey of 513 people with OIC produced 280 text responses concerning the impacts of straining on quality of life and 469 text responses on the meaning OIC symptom relief would confer Text responses about the quality of life impacts of straining often included explicit descriptions conveying physical psychological or practical problems Text responses about the meaning conferred from OIC symptom relief primarily concentrated around freedom from the constraints that OIC can imposePatients are willing and able to comment on the problems OIC cause them using a variety of terms and phrases Their comments concerning impacts on their lives will often refer to physical consequences psychological effects or practical implications These insights provide healthcare practitioners guidance on how to engage patients about OICElizabeth Scarry famously framed a predicament many people with chronic pain find themselves in as “to have great pain is to have certainty to hear that another person has pain is to have doubt” 1 People with chronic pain are thus often haunted by the prospect that those who they depend upon for treatment support and empathy may not believe them Their predicament extends further when they need these others—including healthcare practitioners—to believe that the drugs they take for pain also cause them particular problems such as opioidinduced constipation OICOIC is characterized by a change from baseline bowel habits when initiating opioid therapy and specifically comprises reduced bowel movement frequency development or worsening of straining to pass bowel movements and a sense of incomplete rectal evacuation or harder stool consistency 2 Incidence rates have ranged from 41 across clinical trials involving noncancer patients 3 to 62 in a survey of patients across several cancer clinics 4 and to 86 of cancer and noncancer patients drawn from the National Health and Wellness Survey 5 Many efforts have been directed at discerning the effects and impact of OIC We know OIC causes physical problems 4 5 6 7 along with anxiety distress and fear among other psychological effects 4 7 8 We know it interferes with activities of daily living diminishes quality of life and intrudes upon family interactions 4 5 6 We even know that OIC often upends the efforts of patients to comply with pain management treatment plans and results in higher utilization of healthcare resources 3 4 5 6 7 8 9 Not known nearly as well is how patients verbally express the personal effects and impacts of OIC Knowing how patients verbalize OIC problems as they affect their lives could help clinicians identify new cases educate those initiating opioid therapy and assess cases already under treatmentWe sought verbatim responses from patients with OIC about how the difficulties of bowel movements affect their quality of life and about the importance they attach to experiencing complete bowel movements These verbatim responses were recorded as part of a larger survey concerned with the OIC symptoms patients would most like addressed and the minimal clinically important difference in treating this condition The findings of that aspect of the survey have since been published 10 We report here the findings from the verbatim responses collected from the survey


Keywords:

References


.
Search In Abstract Of Papers:
Other Papers In This Journal:

  1. Azacytidine for the treatment of myelodysplastic syndromes in the elderly
  2. Budget Impact Analysis of a Fixed-Dose Combination of Fluticasone Propionate and Formoterol Fumarate (FP/FORM) in a Pressurized Metered-Dose Inhaler (pMDI) for Asthma
  3. Budget Impact Analysis of a Fixed-Dose Combination of Fluticasone Propionate and Formoterol Fumarate (FP/FORM) in a Pressurized Metered-Dose Inhaler (pMDI) for Asthma
  4. Impacts of Patient Characteristics on the Effectiveness of Landiolol in AF/AFL Patients Complicated with LV Dysfunction: Subgroup Analysis of the J-Land Study
  5. Sunitinib: the First to Arrive at First-Line Metastatic Renal Cell Carcinoma
  6. Adherence to Long-Term Interferon Beta-1b Injection Therapy in Patients with Multiple Sclerosis Using an Electronic Diary
  7. A 6-Month Study Comparing Efficacy, Safety, and Tolerability of the Preservative-free Fixed Combination of Tafluprost 0.0015% and Timolol 0.5% versus Each of Its Individual Preservative-Free Components
  8. Individualized Fludarabine-Based Regimen in Elderly Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
  9. Broadening the perspective when assessing evidence on boosted protease inhibitor-based regimens for initial antiretroviral therapy
  10. Coma caused by isoniazid poisoning in a patient treated with pyridoxine and hemodialysis
  11. The pharmacodynamic properties of azithromycin in a kinetics-of-kill model and implications for bacterial conjunctivitis treatment
  12. Are Dosing Adjustments Required for Colchicine in the Elderly Compared with Younger Patients?
  13. An Overview of Letrozole in Postmenopausal Women with Hormone-Responsive Breast Cancer
  14. Slovak Trial on Cardiovascular Risk Reduction Following National Guidelines with CaDUET® (The STRONG DUET Study)
  15. Pulmonary hypertension, heart failure and neutropenia due to diazoxide therapy
  16. Corneal staining reductions observed after treatment with Systane® Lubricant Eye Drops
  17. Cost-Effectiveness of High Dose Hemodialysis in Comparison to Conventional In-Center Hemodialysis in the Netherlands
  18. Advances in Clinical Cardiology
  19. Efficacy and tolerability of eperisone and baclofen in spastic palsy: a double-blind randomized trial
  20. Dose-Finding Study of Landiolol Hydrochloride: A Short-Acting β 1 -Blocker for Controlling Heart Rate During Coronary Computed-Tomography Angiography in Japan
  21. Fluoroquinolone use is not associated with the change in imipenem susceptibility of Pseudomonas aeruginosa in 25 hospitals
  22. Glial fibrillary acidic protein (GFAP) and CD34 expression in the human optic nerve and brain in methanol toxicity
  23. Urapidil, a dual-acting antihypertensive agent: Current usage considerations

Search Result: